Alaska removes COVID-19 vaccine eligibility restrictions; Affordable Care Act (ACA) health plan subsidies could increase under new relief bill; HHS is reviewing CDC COVID-19–related race and ethnicity data reporting.
Alaska is now allowing anyone who lives or works in the state and is 16 year or older, to receive a COVID-19 vaccine, reported The Washington Post. Close to one-fourth of the state’s residents now have gotten at least 1 vaccine dose, but this expanded eligibility for people 16 to 18 years restricts them to receiving only the Pfizer/BioNTech vaccine. The Johnson & Johnson and Moderna vaccines are only approved for individuals 18 years and older. Pfizer/BioNTech’s vaccine was recently shown to be effective against emerging and more contagious COVID-19 variants from Brazil, the United Kingdom, and South Africa.
The $1.9 trillion coronavirus relief bill proposed by President Joe Biden, currently under a final review by the House of Representatives, could introduce temporary 2-year subsidy increases for Affordable Care Act (ACA) plans, noted The Wall Street Journal. This potential change would mean lowered payments for close to 14 million plan enrollees. Other ACA-related changes included in the bill are no more income cap limits on ACA tax credit eligibility, a new 8.5% household income limit on health care spending, and increased subsidies to lower-income consumers.
Data accuracy is the focus of an investigation by HHS’ inspector general of the CDC’s breakdown of COVID-19–related race and ethnicity reporting, per Politico. Uneven data collection efforts among states, gaps in state and the federal government’s health agencies’ efforts, and missing race/ethnicity information from patients are being pinpointed as possible reasons for the inconsistent reporting of these data. Public health experts note this information is crucial to have because it can help to highlight where interventions are most needed, especially in communities disproportionately affected by the pandemic.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More